Suppression of RANKL-dependent heme oxygenase-1 is required for high mobility group box 1 release and osteoclastogenesis

Eiko Sakai, Megumi Shimada-Sugawara, Kazuhisa Nishishita, Yutaka Fukuma, Mariko Naito, Kuniaki Okamoto, Koji Nakayama, Takayuki Tsukuba

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The differentiation of osteoclasts is regulated by several essential cytokines, such as receptor activator of nuclear factor κB ligand (RANKL) and macrophage colony-stimulating factor. Recently, high mobility group box 1 (HMGB1), a chromatin protein, also has been identified as one of these osteoclast differentiation cytokines. However, the molecular mechanisms that control HMGB1 release from osteoclast precursor cells are not known. Here, we report that RANKL-induced suppression of heme oxygenase-1 (HO-1), a heme-degrading enzyme, promotes HMGB1 release during osteoclastogenesis. In contrast, induction of HO-1 with hemin or curcumin in bone marrow-derived macrophages or RAW-D murine osteoclast precursor cells inhibited osteoclastogenesis and suppressed HMGB1 release. Since an inhibitor for p38 mitogen-activated protein kinase (MAPK) prevented the RANKL-mediated HO-1 suppression and extracellular release of HMGB1, these effects were p38 MAPK-dependent. Moreover, suppression of HO-1 in RAW-D cells by RNA interference promoted the activation of caspase-3 and HMGB1 release, whereas overexpression of HO-1 inhibited caspase-3 activation as well as HMGB1 release. Furthermore, these effects were regulated by redox conditions since antioxidant N-acetylcysteine abolished the HO-1/HMGB1/caspase-3 axis. These results suggest that RANKLdependent HO-1 suppression leads to caspase-3 activation and HMGB1 release during osteoclastogenesis.

Original languageEnglish
Pages (from-to)486-498
Number of pages13
JournalJournal of Cellular Biochemistry
Volume113
Issue number2
DOIs
Publication statusPublished - Feb 2012
Externally publishedYes

Fingerprint

Heme Oxygenase-1
Osteogenesis
Osteoclasts
Caspase 3
Chemical activation
p38 Mitogen-Activated Protein Kinases
Cytokines
Hemin
Curcumin
Macrophage Colony-Stimulating Factor
Somatostatin-Secreting Cells
Macrophages
Acetylcysteine
Cytoplasmic and Nuclear Receptors
RNA Interference
Heme
Chromatin
Oxidation-Reduction
Bone
Antioxidants

Keywords

  • Caspase-3
  • Heme oxygenase
  • High mobility group box 1
  • Osteoclastogenesis
  • RANKL

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Suppression of RANKL-dependent heme oxygenase-1 is required for high mobility group box 1 release and osteoclastogenesis. / Sakai, Eiko; Shimada-Sugawara, Megumi; Nishishita, Kazuhisa; Fukuma, Yutaka; Naito, Mariko; Okamoto, Kuniaki; Nakayama, Koji; Tsukuba, Takayuki.

In: Journal of Cellular Biochemistry, Vol. 113, No. 2, 02.2012, p. 486-498.

Research output: Contribution to journalArticle

Sakai, E, Shimada-Sugawara, M, Nishishita, K, Fukuma, Y, Naito, M, Okamoto, K, Nakayama, K & Tsukuba, T 2012, 'Suppression of RANKL-dependent heme oxygenase-1 is required for high mobility group box 1 release and osteoclastogenesis', Journal of Cellular Biochemistry, vol. 113, no. 2, pp. 486-498. https://doi.org/10.1002/jcb.23372
Sakai, Eiko ; Shimada-Sugawara, Megumi ; Nishishita, Kazuhisa ; Fukuma, Yutaka ; Naito, Mariko ; Okamoto, Kuniaki ; Nakayama, Koji ; Tsukuba, Takayuki. / Suppression of RANKL-dependent heme oxygenase-1 is required for high mobility group box 1 release and osteoclastogenesis. In: Journal of Cellular Biochemistry. 2012 ; Vol. 113, No. 2. pp. 486-498.
@article{91842741c2b343a2bf2c02e1f721d1e0,
title = "Suppression of RANKL-dependent heme oxygenase-1 is required for high mobility group box 1 release and osteoclastogenesis",
abstract = "The differentiation of osteoclasts is regulated by several essential cytokines, such as receptor activator of nuclear factor κB ligand (RANKL) and macrophage colony-stimulating factor. Recently, high mobility group box 1 (HMGB1), a chromatin protein, also has been identified as one of these osteoclast differentiation cytokines. However, the molecular mechanisms that control HMGB1 release from osteoclast precursor cells are not known. Here, we report that RANKL-induced suppression of heme oxygenase-1 (HO-1), a heme-degrading enzyme, promotes HMGB1 release during osteoclastogenesis. In contrast, induction of HO-1 with hemin or curcumin in bone marrow-derived macrophages or RAW-D murine osteoclast precursor cells inhibited osteoclastogenesis and suppressed HMGB1 release. Since an inhibitor for p38 mitogen-activated protein kinase (MAPK) prevented the RANKL-mediated HO-1 suppression and extracellular release of HMGB1, these effects were p38 MAPK-dependent. Moreover, suppression of HO-1 in RAW-D cells by RNA interference promoted the activation of caspase-3 and HMGB1 release, whereas overexpression of HO-1 inhibited caspase-3 activation as well as HMGB1 release. Furthermore, these effects were regulated by redox conditions since antioxidant N-acetylcysteine abolished the HO-1/HMGB1/caspase-3 axis. These results suggest that RANKLdependent HO-1 suppression leads to caspase-3 activation and HMGB1 release during osteoclastogenesis.",
keywords = "Caspase-3, Heme oxygenase, High mobility group box 1, Osteoclastogenesis, RANKL",
author = "Eiko Sakai and Megumi Shimada-Sugawara and Kazuhisa Nishishita and Yutaka Fukuma and Mariko Naito and Kuniaki Okamoto and Koji Nakayama and Takayuki Tsukuba",
year = "2012",
month = "2",
doi = "10.1002/jcb.23372",
language = "English",
volume = "113",
pages = "486--498",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Suppression of RANKL-dependent heme oxygenase-1 is required for high mobility group box 1 release and osteoclastogenesis

AU - Sakai, Eiko

AU - Shimada-Sugawara, Megumi

AU - Nishishita, Kazuhisa

AU - Fukuma, Yutaka

AU - Naito, Mariko

AU - Okamoto, Kuniaki

AU - Nakayama, Koji

AU - Tsukuba, Takayuki

PY - 2012/2

Y1 - 2012/2

N2 - The differentiation of osteoclasts is regulated by several essential cytokines, such as receptor activator of nuclear factor κB ligand (RANKL) and macrophage colony-stimulating factor. Recently, high mobility group box 1 (HMGB1), a chromatin protein, also has been identified as one of these osteoclast differentiation cytokines. However, the molecular mechanisms that control HMGB1 release from osteoclast precursor cells are not known. Here, we report that RANKL-induced suppression of heme oxygenase-1 (HO-1), a heme-degrading enzyme, promotes HMGB1 release during osteoclastogenesis. In contrast, induction of HO-1 with hemin or curcumin in bone marrow-derived macrophages or RAW-D murine osteoclast precursor cells inhibited osteoclastogenesis and suppressed HMGB1 release. Since an inhibitor for p38 mitogen-activated protein kinase (MAPK) prevented the RANKL-mediated HO-1 suppression and extracellular release of HMGB1, these effects were p38 MAPK-dependent. Moreover, suppression of HO-1 in RAW-D cells by RNA interference promoted the activation of caspase-3 and HMGB1 release, whereas overexpression of HO-1 inhibited caspase-3 activation as well as HMGB1 release. Furthermore, these effects were regulated by redox conditions since antioxidant N-acetylcysteine abolished the HO-1/HMGB1/caspase-3 axis. These results suggest that RANKLdependent HO-1 suppression leads to caspase-3 activation and HMGB1 release during osteoclastogenesis.

AB - The differentiation of osteoclasts is regulated by several essential cytokines, such as receptor activator of nuclear factor κB ligand (RANKL) and macrophage colony-stimulating factor. Recently, high mobility group box 1 (HMGB1), a chromatin protein, also has been identified as one of these osteoclast differentiation cytokines. However, the molecular mechanisms that control HMGB1 release from osteoclast precursor cells are not known. Here, we report that RANKL-induced suppression of heme oxygenase-1 (HO-1), a heme-degrading enzyme, promotes HMGB1 release during osteoclastogenesis. In contrast, induction of HO-1 with hemin or curcumin in bone marrow-derived macrophages or RAW-D murine osteoclast precursor cells inhibited osteoclastogenesis and suppressed HMGB1 release. Since an inhibitor for p38 mitogen-activated protein kinase (MAPK) prevented the RANKL-mediated HO-1 suppression and extracellular release of HMGB1, these effects were p38 MAPK-dependent. Moreover, suppression of HO-1 in RAW-D cells by RNA interference promoted the activation of caspase-3 and HMGB1 release, whereas overexpression of HO-1 inhibited caspase-3 activation as well as HMGB1 release. Furthermore, these effects were regulated by redox conditions since antioxidant N-acetylcysteine abolished the HO-1/HMGB1/caspase-3 axis. These results suggest that RANKLdependent HO-1 suppression leads to caspase-3 activation and HMGB1 release during osteoclastogenesis.

KW - Caspase-3

KW - Heme oxygenase

KW - High mobility group box 1

KW - Osteoclastogenesis

KW - RANKL

UR - http://www.scopus.com/inward/record.url?scp=84855554307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855554307&partnerID=8YFLogxK

U2 - 10.1002/jcb.23372

DO - 10.1002/jcb.23372

M3 - Article

VL - 113

SP - 486

EP - 498

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 2

ER -